Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seonaid Nolan

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Drug and Alcohol Review|March 23, 2017
Addressing the prescription opioid crisis: Potential for hospital-based interventions?Brian Kim, Seonaid Nolan, Lianping Ti
Journal of Addiction Medicine|October 29, 2019
Sustained-release Oral Hydromorphone for the Treatment of Opioid Use DisorderVivian Braithwaite, Christopher Fairgrieve, Seonaid Nolan
Journal of Epidemiology and Community Health|May 18, 2019
Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease periodTara Beaulieu, Seonaid Nolan, Lianping Ti
Drug and Alcohol Review|June 13, 2024
Characterising individuals with a substance use disorder accessing hospital-based addiction care: Preliminary description of the outcomes for patients accessing addiction care prospective cohort studyHannah James, Jeffrey Morgan, Seonaid Nolan
Journal of Addiction Medicine|March 7, 2020
Case Study: Naltrexone for the Treatment of Nitrous Oxide UseSarah Ickowicz, Rupinder Brar, Seonaid Nolan
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2020
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug marketPrivia A Randhawa, Rupinder Brar, Seonaid Nolan
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Journal of Addiction Medicine|October 25, 2021
Moving Away From a "One Size Fits All" Model: Ensuring Opioid Stewardship Includes People Who Use DrugsSarah Poteryko, Seonaid Nolan, Tamara Mihic, et al.
Journal of Addiction Medicine|March 15, 2022
Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management?Jonah Hamilton, Lianping Ti, Mo Korchinski, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Drug and Alcohol Review|March 23, 2017
Addressing the prescription opioid crisis: Potential for hospital-based interventions?Brian Kim, Seonaid Nolan, Lianping Ti
Journal of Addiction Medicine|October 29, 2019
Sustained-release Oral Hydromorphone for the Treatment of Opioid Use DisorderVivian Braithwaite, Christopher Fairgrieve, Seonaid Nolan
Journal of Epidemiology and Community Health|May 18, 2019
Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease periodTara Beaulieu, Seonaid Nolan, Lianping Ti
Drug and Alcohol Review|June 13, 2024
Characterising individuals with a substance use disorder accessing hospital-based addiction care: Preliminary description of the outcomes for patients accessing addiction care prospective cohort studyHannah James, Jeffrey Morgan, Seonaid Nolan
Journal of Addiction Medicine|March 7, 2020
Case Study: Naltrexone for the Treatment of Nitrous Oxide UseSarah Ickowicz, Rupinder Brar, Seonaid Nolan
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2020
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug marketPrivia A Randhawa, Rupinder Brar, Seonaid Nolan
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Journal of Addiction Medicine|October 25, 2021
Moving Away From a "One Size Fits All" Model: Ensuring Opioid Stewardship Includes People Who Use DrugsSarah Poteryko, Seonaid Nolan, Tamara Mihic, et al.
Journal of Addiction Medicine|March 15, 2022
Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management?Jonah Hamilton, Lianping Ti, Mo Korchinski, et al.
Pageof 12